UPDATE: EpiPen® (Adrenaline) auto-injector availability

 

Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand

Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.

The recall of Emerade 500 microgram auto-injectors follows the previous recalls of Emerade 150 and 300 microgram auto-injectors. More information on the previous alerts can be found on the following links below. The Emerade pens were recalled in three phases to ensure there would be enough supplies of the alternative pens, EpiPen or Jext, available for patients.

• 150 mcg recall
• 300 mcg recall

Information is available regarding this switch on the following MHRA website page:

• https://www.gov.uk/government/news/patients-informed-to-exchange-emerade-500-micrograms-adrenaline-pens-for-a-different-brand

Anaphylactic Guidance regarding dosing is available in the following statement from the Resuscitation Council UK:

• https://www.resus.org.uk/media/statements/statement-on-anaphylactic-guidelines/

---

EpiPen® (Adrenaline) auto-injector availability update

Mylan have provided the following information sheet regarding availability of 0.3mg and 0.15mg adrenaline auto-injectors:

• EpiPen® (Adrenaline) auto-injector availability update 

---

Further information regarding training resources for EpiPen®

For Healthcare Professionals:

• https://www.mylanconnects.co.uk/ 

For patients:

• http://www.epipen.co.uk/ 

SmPCs:

• https://www.medicines.org.uk/emc/medicine/26974           
• https://www.medicines.org.uk/emc/product/4290/smpc